Nico Golfrè Andreasi

@istituto-besta.it

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

RESEARCH INTERESTS

Neurology, movement disorder, deep brain stimulation, levodopa-carbidopa intestinal gel
32

Scopus Publications

Scopus Publications

  • Polyelectromyography Under Propofol to Differentiate Functional from Idiopathic Dystonia: A Pilot Study
    Roberto Eleopra, Fabio Paio, Sara Rinaldo, Carla Carozzi, Amanda Oriana, et al.
    Movement Disorders, 2026
    Background Functional dystonia ( FD ) is one of the most diagnostically challenging functional movement disorders. Phenomenological features often lack specificity, as many are also observed in idiopathic dystonia ( ID ) and validated biomarkers to distinguish FD from ID are currently unavailable Objective To investigate potential differences in muscle activity between ID and FD patients using polyelectromyography (PEMG) under anesthesia. Methods We consecutively enrolled 10 patients with FD and 17 with ID according to the current diagnostic criteria who underwent continuous PEMG before, during, and after propofol infusion. Sedation levels were monitored by electroencephalography and bispectral index and stratified via the Observer's Assessment of Alertness/Sedation Scale (OASS). PEMG recordings were performed under five definite scenarios: alert, mild and deep sedation, and partial and full recovery of consciousness status. Presence/absence of EMG activity was evaluated across these stages, and changes from baseline patterns were analyzed. Results During mild sedation, EMG activity persisted in all ID (100%) and in 9 (90%) FD patients. During deep sedation, EMG activity persisted in 9 (53%) ID patients and was absent in all FD patients (100%) ( P = 0.01). During partial recovery of consciousness, EMG activity was present in all (100%) ID and only in 1 (10%) FD patients ( P < 0.001). At full recovery, a different muscular activation pattern from baseline was observed in 7 (70%) FD and only in 1 (6%) ID patients ( P = 0.001) Conclusions EMG silence during deep sedation and partial recovery may serve as a neurophysiological marker of FD . A muscular activation pattern differing from baseline may represent a neurophysiological clue for incongruence © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
  • The Role of MER Processing Pipelines for STN Functional Identification During DBS Surgery: A Feature-Based Machine Learning Approach
    Vincenzo Levi, Stefania Coelli, Chiara Gorlini, Federica Forzanini, Sara Rinaldo, et al.
    Bioengineering, 2025
    Microelectrode recording (MER) is commonly used to validate preoperative targeting during subthalamic nucleus (STN) deep brain stimulation (DBS) surgery for Parkinson’s Disease (PD). Although machine learning (ML) has been used to improve STN localization using MER data, the impact of preprocessing steps on the accuracy of classifiers has received little attention. We evaluated 24 distinct preprocessing pipelines combining four artifact removal strategies, three outlier handling methods, and optional feature normalization. The effect of each data processing procedure’s component of interest was evaluated in function of the performance obtained using three ML models. Artifact rejection methods (i.e., unsupervised variance-based algorithm (COV) and background noise estimation (BCK)), combined with optimized outlier management (i.e., statistical outlier identification per hemisphere (ORH)) consistently improved classification performance. In contrast, applying hemisphere-specific feature normalization prior to classification led to performance degradation across all metrics. SHAP (SHapley Additive exPlanations) analysis, performed to determine feature importance across pipelines, revealed stable agreement with regard to influential features across diverse preprocessing configurations. In conclusion, optimal artifact rejection and outlier treatment are essential in preprocessing MER for STN identification in DBS, whereas preliminary feature normalization strategies may impair model performance. Overall, the best classification performance was obtained by applying the Random Forest model to the dataset treated using COV artifact rejection and ORH outlier management (accuracy = 0.945). SHAP-based interpretability offers valuable guidance for refining ML pipelines. These insights can inform robust protocol development for MER-guided DBS targeting.
  • Age-matched comparison of focused ultrasound thalamotomy for tremor in Parkinson's disease and essential tremor: A two-center retrospective study
    Gianfranco Gaudiano, Cletus Cheyuo, Arianna Braccia, Nico Golfrè Andreasi, Vincenzo Levi, et al.
    Parkinsonism and Related Disorders, 2025
  • Simultaneous MEG-LFP Recordings to Assess In Vivo Dystonic Neurophysiological Networks: A Feasibility Study
    Elisa Visani, Lorenzo Bergamini, Chiara Gorlini, Dunja Duran, Nico Golfrè Andreasi, et al.
    Brain Sciences, 2025
    Background/Objectives: Subcortical local field potentials (LFPs) provide a valuable in vivo window into the neurophysiology of the dystonia network. These signals can be recorded through Deep Brain Stimulation (DBS) devices and combined with whole-head techniques such as magnetoencephalography (MEG) to study cortical–subcortical interactions. However, simultaneous LFP-MEG acquisition poses challenges, including interference from the DBS device and synchronization issues. We present preliminary data on the feasibility and signal quality of concurrent LFP and MEG recordings in dystonia patients. Methods: We assessed simultaneous MEG-LFP recordings in 11 patients with inherited or idiopathic dystonia who underwent bilateral DBS lead implantation in the Globus Pallidus Internus (GPi). Two synchronization strategies were tested: (1) the Tapping method, using an accelerometer placed on the DBS device, and (2) the Stimulation method, which generated detectable artifacts during sham stimulation. Results: Both methods successfully aligned MEG and LFP signals with a mean temporal delay of 91 ± 22 ms for the Tapping method and 288 ± 166 ms for the Stimulation method. Post-implantation signal-to-noise ratio analysis revealed slight degradation but no significant impact on MEG quality (gradiometers: −0.12 ± 1.85 dB; magnetometers: −0.47 ± 2.03 dB). Conclusions: Simultaneous MEG-LFP recordings in dystonic patients are feasible, yielding high-quality signals, and reliable synchronization. Temporal alignment improved with practice, suggesting a short learning curve. This method opens new opportunities to study cortical-subcortical dynamics and strengthens the potential of combining MEG-LFP approaches for investigating dystonia.
  • Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant
    Micol Avenali, Carlo Alberto Artusi, Roberto Cilia, Giulia Giannini, Giada Cuconato, et al.
    Neurology, 2025
  • Deep Brain Stimulation for VPS16-Related Dystonia: A Multicenter Study
    Tatiana Svorenova, Luigi M. Romito, Ahmet Kaymak, Eoin Mulroy, Laura Cif, et al.
    Annals of Neurology, 2025
    ObjectiveThe objective was to evaluate the effects of deep brain stimulation (DBS) in an international cohort of patients with VPS16‐related dystonia.MethodsThis observational study collected preoperative and postoperative demographic, clinical, stimulation, genetic, neuroimaging, and neurophysiological data of medically refractory DYT‐VPS16 patients with implanted DBS in 10 international centers. Motor symptoms and disability outcomes were assessed using the Burke‐Fahn‐Marsden Dystonia Rating Scale Motor (BFMDRS‐M) and Disability (BFMDRS‐D) scales. A cut‐off threshold for considering response to DBS was set at 25% of BFMDRS‐M improvement at the last follow‐up (FU) compared to baseline.ResultsThe cohort consisted of 26 participants (17 men, 65.4%). Age at dystonia onset and surgery was 17.8 ± 10.9 and 35.3 ± 14.8 years, respectively. At the last FU, 102.5 ± 57.3 months (range, 2–216), the mean BFMDRS‐M improvement was 41.6 ± 37.3% (26/26 patients) and 34.8 ± 42.6% for the BFMDRS‐D (23/26 patients). Most patients (19/26, 73%) were considered responders. Higher motor improvement was associated with stimulation of the ventroposterior portion of the internal globus pallidus. A significant inverse relationship was observed between improvement in BFMDRS‐M at last FU, and the presence of spasticity (p = 0.027) and fixed skeletal deformities (p = 0.001) before surgery. Non‐responders had a younger age at disease onset and at implantation, shorter disease duration at DBS surgery, and higher baseline BFMDRS scores.InterpretationDBS was an effective treatment for three‐quarters of patients with pathogenic VPS16 variants in our cohort. Mean motor improvement was most pronounced at the 1‐year FU, but persisted at the last FU despite disease progression. ANN NEUROL 2025
  • Magnetic Resonance–Guided Focused Ultrasound Thalamotomy in a Prospective Cohort of 52 Patients with Parkinson's Disease: A Possible Critical Role of Age and Lesion Volume for Predicting Tremor Relapse
    Arianna Braccia, Nico Golfrè Andreasi, Francesco Ghielmetti, Domenico Aquino, Anna Paola Savoldi, et al.
    Movement Disorders, 2025
    BackgroundMagnetic resonance–guided focused ultrasound (MRgFUS) thalamotomy of ventral intermediate (Vim) nucleus is useful to treat drug‐resistant tremor‐dominant Parkinson's disease (TdPD), but tremor relapse may occur. Predictors of relapse have been poorly investigated so far.ObjectiveThe aim of this study is to evaluate the role of clinico‐demographic, procedural, and neuroradiological variables in determining clinical response, relapse, and adverse events (AEs) in TdPD after MRgFUS Vim‐thalamotomy.MethodsFifty‐two TdPD patients who consecutively underwent unilateral MRgFUS Vim‐thalamotomy were prospectively evaluated at baseline and after 24 hours, 1 month, 6 months, and 12 months using MDS‐UPDRS‐III in off and on medication conditions. AEs were collected at each evaluation. Lesion volume was calculated at 24‐hour magnetic resonance imaging (MRI). Patients with tremor improvement <30% in off medication were considered nonresponders (when detected after 24 hours) or relapsers (if detected from 1‐month visit onward).ResultsAll patients showed tremor improvement >30% at 24 hours. Tremor relapse occurred in 12 patients (23%), exclusively during the first month after thalamotomy. Relapse was associated with younger age (P = 0.030) and smaller lesion volume (P = 0.030). At 1 month, 22 patients (42%) had AEs; at 6 and 12 months, AEs persisted in 19% and 6% of cases. AEs at 6 months were associated with larger lesions (P = 0.018). All AEs were mild.ConclusionsMRgFUS Vim‐thalamotomy is effective in treating tremor in TdPD. Relapse is associated with younger age and smaller lesion volume, but larger lesions make AEs more likely to persist. We suggest that a lesion volume between 145 and 220 mm3 on T1‐weighted MRI may be the therapeutic window that ensures tremor control without long‐lasting AEs. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
  • Quantitative Tractography-Based Evaluations in Essential Tremor Patients after MRgFUS Thalamotomy
    Francesco Ghielmetti, Domenico Aquino, Nico Golfrè Andreasi, Federica Mazzi, Elena Greco, et al.
    Movement Disorders Clinical Practice, 2024
    BackgroundMagnetic resonance‐guided focused ultrasound (MRgFUS) targeting the thalamic ventral intermediate nucleus (VIM) is an innovative treatment for drug‐refractory essential tremor (ET). The relationship between lesion characteristics, dentate‐rubro‐thalamic‐tract (DRTT) involvement and clinical benefit remains unclear.ObjectivesTo investigate whether clinical outcome is related to lesion volume and/or its overlap with the DRTT. To compare the reliability of probabilistic versus deterministic tractography in reconstructing the DRTT and improving VIM targeting.MethodsForty ET patients who underwent MRgFUS thalamotomy between 2019 and 2022 were retrospectively analyzed. Clinical outcomes and adverse effects were recorded at 1/6/12 months after the procedure. The DRTT was generated using deterministic and probabilistic tractography on preoperative diffusion‐tensor 3 T‐images and location and volume of the lesion were calculated.ResultsProbabilistic tractography identified both decussating (d‐DRTT) and non‐decussating (nd‐DRTT) components of the DRTT, whereas the deterministic approach only identified one component overlapping with the nd‐DRTT. Despite the lesions predominantly intersecting the medial portion of the d‐DRTT, with a significantly greater overlap in responder patients, we observed only a non‐significant correlation between tremor improvement and increased d‐DRTT‐lesion overlap (r = 0.22, P = 0.20). The lesion volume demonstrated a significant positive correlation with clinical improvement at 1‐day MRI (r = 0.42, P < 0.01).ConclusionVariability in the reconstructed DRTT position relative to the lesion center of mass, even among good responders, suggests that this fiber bundle is unlikely to be considered the sole target for a successful MRgFUS thalamotomy in ET. Indirect individualized targeting allows for more precise and reproducible identification of actual treatment coordinates than the direct method.
  • Pain related to MRgFUS: a merely minor transient adverse event?
    Paolo Amami, Sara Prioni, Marco Fusar Poli, Riccardo Pascuzzo, Elisa Bocchi, et al.
    Journal of Neurology Neurosurgery and Psychiatry, 2024
  • Aceruloplasminemia: Unique Clinical and MRI Findings in a Patient with a Novel Frameshift Mutation
    Fabiana Colucci, Silvia Barca, Roberto Cilia, Valentino De Franco, Antonio E. Elia, et al.
    Movement Disorders Clinical Practice, 2024
  • Bilateral Simultaneous Magnetic Resonance–Guided Focused Ultrasound Pallidotomy for Life-Threatening Status Dystonicus
    Vincenzo Levi, Mario Stanziano, Carmela Pinto, Federica Zibordi, Davide Fedeli, et al.
    Movement Disorders, 2024
  • Genome Aggregation Database Version 4—New Challenges of Variant Analysis in Movement Disorders
    Elisabetta Indelicato, Luigi Michele Romito, Philip Harrer, Nico Golfrè Andreasi, Isabel Colangelo, et al.
    Movement Disorders, 2024
  • Illustration of the long-term efficacy of pallidal deep brain stimulation in a patient with PKAN dystonia
    Luigi M. Romito, Fabiana Colucci, Giovanna Zorzi, Barbara Garavaglia, Ahmet Kaymak, et al.
    Parkinsonism and Related Disorders, 2024
  • Early cortico-muscular coherence and cortical network changes in Parkinson’s patients treated with MRgFUS
    Elisa Visani, Ferruccio Panzica, Silvana Franceschetti, Nico Golfrè Andreasi, Roberto Cilia, et al.
    Frontiers in Neurology, 2024
  • The Optimal Targeting for Focused Ultrasound Thalamotomy Differs between Dystonic and Essential Tremor: A 12-Month Prospective Pilot Study
    Nico Golfrè Andreasi, Arianna Braccia, Vincenzo Levi, Sara Rinaldo, Francesco Ghielmetti, et al.
    Movement Disorders Clinical Practice, 2024
  • Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA -associated Parkinson's disease: A multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
    Fabiana Colucci, Micol Avenali, Rosita De Micco, Marco Fusar Poli, Silvia Cerri, et al.
    BMJ Neurology Open, 2023
  • Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study
    Roberto Cilia, Emanuele Cereda, Marco Piatti, Andrea Pilotto, Luca Magistrelli, et al.
    Movement Disorders Clinical Practice, 2023
  • Magnetic Resonance–Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early-Stage Tremor-Dominant Parkinson's Disease: A Pilot Study
    Nico Golfrè Andreasi, Roberto Cilia, Luigi Michele Romito, Salvatore Bonvegna, Giulia Straccia, et al.
    Movement Disorders, 2022
  • Development of Parkinsonism in a Patient with Central Pontine Myelinolysis
    Annibale Antonioni, Vittorio Rispoli, Patrik Fazio, Nico Golfrè Andreasi, Vittorio Govoni, et al.
    Neurology International, 2022
  • Cerebrospinal fluid neuropathological biomarkers in beta-propeller protein-associated neurodegeneration, with complicated parkinsonian phenotype
    Roberta Bonomo, Antonio E. Elia, Roberto Cilia, Luigi M. Romito, Nico Golfrè Andreasi, et al.
    Parkinsonism and Related Disorders, 2022
  • Short- and long-term motor outcome of STN-DBS in Parkinson’s Disease: focus on sex differences
    Nico Golfrè Andreasi, Luigi Michele Romito, Roberta Telese, Roberto Cilia, Antonio Emanuele Elia, et al.
    Neurological Sciences, 2022
  • Resting State Functional Connectivity Signatures of MRgFUS Vim Thalamotomy in Parkinson's Disease: A Preliminary Study
    Mario Stanziano, Nico Golfrè Andreasi, Giuseppe Messina, Sara Rinaldo, Sara Palermo, et al.
    Frontiers in Neurology, 2022
  • Globus Pallidus Internus Deep Brain Stimulation Using Frame-Based vs. Frameless Stereotaxy in Dystonia: A Single-Center Experience
    Roberto Eleopra, Sara Rinaldo, Grazia Devigili, Massimo Mondani, Stanislao D'Auria, et al.
    Frontiers in Neurology, 2021
  • Parkinsonism and Nigrostriatal Damage Secondary to CSF1R-Related Primary Microgliopathy
    Salvatore Bonvegna, Giulia Straccia, Nico Golfrè Andreasi, Antonio Emanuele Elia, Gianluca Marucci, et al.
    Movement Disorders, 2020
  • Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study
    Roberto Cilia, Salvatore Bonvegna, Giulia Straccia, Nico Golfrè Andreasi, Antonio E. Elia, et al.
    Movement Disorders, 2020